Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 11 (1) , 1-11
- https://doi.org/10.1016/0735-1097(88)90158-1
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- High-dose, brief-duration intravenous infusion of streptokinase in acute myocardial infarction: Description of effects in the circulationThe American Journal of Cardiology, 1986
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Thrombolytic therapy in patients with acute myocardial infarction.Circulation, 1985
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.Circulation, 1984
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator.Circulation, 1984
- Thrombolytic TherapyNew England Journal of Medicine, 1984
- Hemorrhage and the products of fibrinogen digestion after intracoronary administration of streptokinase.Circulation, 1984
- Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial InfarctionNew England Journal of Medicine, 1984
- Fibrinolytic effects of intracoronary streptokinase administration in patients with acute myocardial infarction and coronary insufficiency.Circulation, 1983
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980